Foundation Council

Professor Dr. Rudolf Tauber, Chair

Professor Tauber holds the chair for Clinical Chemistry and Pathobiochemistry at the Charité - University Medicine Berlin and is director of the Institute of Laboratory Medicine, Clinical Chemistry, and Pathobiochemistry. He is also director of the Department of Laboratory Medicine and Toxicology and scientific director of the Labor Berlin Charité Vivantes GmbH. His main fields of interest are the pathogenesis of diseases and the development of new diagnostic and therapeutic methods and strategies. Professor Tauber is a member of numerous scientific associations. In 2011 he was appointed to the Scientific Advisory Council of the German Tinnitus Foundation Charité. In July 2013 he was appointed chair of the Foundation Council.

Dr.-Ing. E.h. Heinz Dürr

Heinz Dürr is chair of the Supervisory Board of the Dürr AG Stuttgart, one of the world's leading suppliers of products, systems, and service for the automotive and aircraft industries. He restructured the AEG Group and from 1991 was responsible for fusing the East and West German rail systems (Deutsche Bundesbahn and Deutsche Reichsbahn). He has played a decisive role in railway reform in Germany. Together with his wife, he established the HEINZ AND HEIDE DÜRR FOUNDATION, which promotes research, especially in human genetics and molecular biology, and which has also gained renown in the fields of early childhood education and the German-speaking theatre.

Ines Kolmsee

After completing her studies at the Technical University Berlin in Energy and Process Engineering and further studies at the Ecole des Mines in St. Etienne, Ines Kolmsee has since 2006 been CEO of the SKW Stahl-Metallurgie Holding AG. The group sells products for the desulphurisation of pig iron and steel throughout the world. Ines Kolmsee is the only woman CEO of a Dax-listed concern. In 2011 she received the Manager Award of the Federal Association of German Business Consultants.

Professor Dr. Rudolf Morgenstern

Until 1994, Professor Morgenstern was senior physician at the Institute of Pharmacology and Toxicology at the Charité. He was appointed university professor of pharmacology in 1994 . And in 1996 he was appointed managing director of the Institute of Pharmacology and Toxicology of the Charité. Professor Morgenstern is deputy chair of the ethics commission of the Charité and member of a number of international scientific associations.

Dr. Holger Hatje, Deputy Chair

The CEO of the Berliner Volksbank eG is engaged in an honorary capacity in Berlin Partner GmbH, the Berliner Wirtschaftsgespräche (a forum for economic policy debate), the Zoologischer Garten Berlin, and the soccer club Hertha BSC. He explains his engagement in the German Tinnitus Foundation Charité as follows: “The Foundation addresses a disorder that can affect any of us. Safeguarding and promoting health has become a vital task in society. Particularly in this respect, you have to look at both sides of every decision and ask what it costs to do nothing.”

Professor Dr. Dr. h.c. Norbert P. Haas

Professor Norbert P. Haas, professor at the Charité since 1992, was in 2003 appointed director of the Center for Musculoskeletal Surgery at the Charité–University Medicine Berlin, comprising the Departments of Traumatology and Reconstructive Surgery and Orthopedic Surgery. The Center is the biggest traumatology and orthopedic center in Germany. Professor Haas is a member or honorary member of numerous national and international scientific societies, institutions, editorial boards and advisory bodies. In 2007 he was awarded an honorary doctorate by the Voronezh State Medical Academy–Burdenko Academy, Russia.

Martin Menking

The cellist joined the Berlin Philharmonic Orchestra in 1996. Martin Menking also plays in various chamber music ensembles with colleagues, above all in the renowned “12 Cellists,” of which he is the managing director. As a member of the 12 Cellists but also as a soloist, Martin Menking has received many public awards. “Tinnitus/hearing disorders is a subject that affects practically all of us. That is why we gave a benefit concert on the occasion of the establishement of the foundation, and why I remain committed to the project.”

Professor Dr. Heidi Olze

Professor Olze is managing director of the Ear, Nose and Throat Clinic of the Charité - University Medicine Berlin at the Campus Virchow Clinic and the Campus Charité Mitte. The clinic treats all forms of hearing disorders, which are often associated with tinnitus. It accordingly offers a broad range of treatment from hearing-improvement operations to middle-ear and cochlear implants and brain stem implants. Apart from the surgical treatment, Professor Olze also conducts clinical and basic research on auditory implants. “Hearing improvement and tinnitus reduction often go hand in hand – it is vital to understand how they are linked. This is why I am actively engaged in the German Tinnitus Foundation Charité.”